Vitreous cavity replacement with SiO is indicated in complex retinal reattachment surgery in dogs by providing long-term retinal tamponade. Use of SiO in dogs is desirable because they are unable to maintain a stable head position for several hours per day and because of the extensive nature of retinal detachment in dogs. Several complications have been reported for SiO use as a permanent tamponade in humans,1 rabbits,2 nonhuman primates,3 and dogs.4,5 These complications include SiO emulsification,1,6 anterior chamber migration,4,5 keratopathy,6–8 glaucoma,2 cataract formation,5 inner retinal toxic effects,9–11 and subconjunctival migration from sclerotomy sites.9
Keratopathy and glaucoma are more common in aphakic and, to a lesser extent, pseudophakic eyes, potentially allowing easier access of oil to the anterior chamber than in other eyes.10,11 Keratopathy and glaucoma in dogs are more likely to develop with emulsification of the SiO in the anterior chamber. Emulsification occurs more commonly with less viscous versus more viscous SiOs and with SiOs containing higher versus lower amounts of impurities.
Removal of SiO from canine and human eyes can lead to retinal slippage or recurrence of the retinal detachment. In dogs, SiO is rarely removed, whereas in humans, removal is performed most often between 2 and 6 months after surgery to help avoid cataract formation and proliferative vitreoretinopathy and to correct anisometropia.6 Given that the refractive indices of SiO and vitreous humor are different (1.405 and 1.336 D, respectively),12 surgeons should consider the possible refractive changes induced following vitreous humor replacement, which, to the authors' knowledge, has not been determined in dogs. The purpose of the study reported here was to evaluate ocular refractive error following retinal reattachment surgery and SiO tamponade in dogs.
Fluress, Akorn Inc, Lake Forest, Ill.
Intervet/Schering-Plough Animal Health Inc, Roseland, NJ.
TonoVet, Tiolat TV01, Helsinki, Finland.
Kowa SL-14 portable slit lamp, CR Medical, Linz, Austria.
Keeler Wireless, Keeler Ltd, Windsor, Berkshire, England.
Acri.Octa, S.V. & Technologies AG, Hennigsdorf, Germany.
Acri.SIL-OL. S V. & Technologies AG, Hennigsdorf, Germany.
OPMI-6-S, Carl Zeiss AG, Aalen, Germany.
VOLK ROLS, Mentor, Ohio.
Eibos HS, Möeller-Wedel GmbH, Wedel, Germany.
MedOne Surgical Inc, Sarasota, Fla.
Dutch Ophthalmic, Exeter, NH.
Alcon Laboratories Inc, Fort Worth, Tex.
DioVet, Iridex Corp, Mountainview, Calif.
Ethicon Inc, Somerville, NJ.
Heine BETA TR 3.5 V, Heine Optotechnik GmbH & Co, Herrsching, Germany.
L2 Retinoscopy racks, Luneau Ophtalmologie, Chartres Cedex, France.
1 Nakamura K, Refojo MF, Crabtree DV. Factors contributing to the emulsification of intraocular silicone and fluorosilicone oils. Invest Ophthalmol Vis Sci 1990; 31: 647–656.
2 Chan C, Okun E. The question of ocular tolerance to intravitreal liquid silicone. A long-term analysis. Ophthalmology 1986; 93: 651–660.
10 Nazemi PP, Chong LP, Varma R, et al. Migration of intraocular silicone oil into the subconjunctival space and orbit through an Ahmed glaucoma valve. Am J Ophthalmol 2001; 132: 929–931.
12 McCartney DL, Miller KM, Stark WJ, et al. Intraocular lens style and refraction in eyes treated with silicone oil. Arch Ophthalmol 1987; 105: 1385–1387.
13 Hutton WL, Azen SP, Blumenkranz MS, et al. The effects of silicone oil removal. Silicone study report 6. Arch Ophthalmol 1994; 112: 778–785.
14 Gabel VP, Kampik A, Gabel C, et al. Silicone oil with high specific gravity for intraocular use. Br J Ophthalmol 1987; 71: 262–267.
17 Grinbaum A, Treister G, Moisseiev J. Predicted and actual refraction after intraocular lens implantation in eyes with silicone oil. J Cataract Refract Surg 1996; 22: 726–729.
18 Davidson MG, Murphy CJ, Nasisse MP, et al. Refractive state of aphakic and pseudophakic eyes of dogs. Am J Vet Res 1993; 54: 174–177.
21 Gao Q, Chen X, Ge J, et al. Refractive shifts in four selected artificial vitreous substitutes based on Gullstrand-Emsley and Liou-Brennan schematic eyes. Invest Ophthalmol Vis Sci 2009; 50: 3529–3534.
23 Stefansson E, Anderson MM Jr, Landers MB III, et al. Refractive changes from use of silicone oil in vitreous surgery. Retina 1988; 8: 20–23.
24 Launay F, Laroche G, Limon S. Changes in refraction after intravitreal silicone oil injections [in French]. J Fr Ophtalmol 1982; 5: 417–425.
25 Dick HB, Schwenn O, Pavlovic S, et al. Effect of head position on refraction in aphakic and phakic silicone-filled eyes. Retina 1997; 17: 397–402.
26 Gilger BC, Davidson MG, Howard PB. Keratometry, ultrasonic biometry, and prediction of intraocular lens power in the feline eye. Am J Vet Res 1998; 59: 131–134.
27 Cottrill NB, Banks WJ, Pechman RD. Ultrasonographic and biometric evaluation of the eye and orbit of dogs. Am J Vet Res 1989; 50: 898–903.
31 Fledelius HC, Scherfig E. The acoustic lighthouse effect. An ultrasonic response met in eyes after vitreoretinal surgery with silicone oil. Acta Ophthalmol Scand 2000; 78: 89–92.
32 Ghoraba HH, El-Dorghamy AA, Atia AF, et al. The problems of biometry in combined silicone oil removal and cataract extraction: a clinical trial. Retina 2002; 22: 589–596.
33 Nepp J, Krepler K, Jandrasits K, et al. Biometry and refractive outcome of eyes filled with silicone oil by standardized echography and partial coherence interferometry. Graefes Arch Clin Exp Ophthalmol 2005; 243: 967–972.
34 Bencic G, Vatavuk Z, Marotti M, et al. Comparison of A-scan and MRI for the measurement of axial length in silicone oil-filled eyes. Br J Ophthalmol 2009; 93: 502–505.
35 Takei K, Sekine Y, Okamoto F, et al. Measurement of axial length of eyes with incomplete filling of silicone oil in the vitreous cavity using x-ray computed tomography. Br J Ophthalmol 2002; 86: 47–50.
36 Seo MS, Lim ST, Kim HD, et al. Changes in refraction and axial length according to the viscosity of silicone oil. Korean J Ophthalmol 1999; 13: 25–29.